Literature DB >> 29649536

Characterization of Momordica charantia L. polysaccharide and its protective effect on pancreatic cells injury in STZ-induced diabetic mice.

Cong Zhang1, Hongman Chen2, Weiqi Bai1.   

Abstract

A polysaccharide with a molecular weight of 13,029Da was isolated from Momordica charantia (MCP) fruit and purified by ion-exchange and size-exclusion chromatography. The isolated polysaccharide MCPIIa contained L-Rha, D-GalA, D-Gal, D-Xyl, L-Ara in a molar ratio of 12:3.05:19.89:5.95:56. IR spectrum and NMR studies indicated that the MCPIIa sugar units were linked, via β-glycosidic bonds, to a large number of arabinofuranose, glucuronic acid, and xylopyranosyl residues. In addition, the hypoglycemic effect of MCPIIa was investigated in streptozotocin (STZ)-induced diabetic mice. After STZ-induction, MCPIIa (100, 200, or 300mg/kg body weight) was administered orally, once daily, for 28days. Glycemia in STZ-diabetogenic mice was significantly reduced, and compared with diabetes mellitus (DM) mice, serum insulin concentration increased significantly, following MCPIIa administration. Transmission electron microscopy showed an alleviation of STZ-lesions in pancreatic tissue from mice treated with MCPIIa. These results indicate that MCPIIa may be useful as an anti-diabetic agent.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Characterization; Momordica charantia L. polysaccharide; Pancreatic protective effect

Mesh:

Substances:

Year:  2018        PMID: 29649536     DOI: 10.1016/j.ijbiomac.2018.04.039

Source DB:  PubMed          Journal:  Int J Biol Macromol        ISSN: 0141-8130            Impact factor:   6.953


  5 in total

Review 1.  Nutritional Value, Phytochemical Potential, and Therapeutic Benefits of Pumpkin (Cucurbita sp.).

Authors:  Maria Batool; Muhammad Modassar Ali Nawaz Ranjha; Ume Roobab; Muhammad Faisal Manzoor; Umar Farooq; Hafiz Rehan Nadeem; Muhammad Nadeem; Rabia Kanwal; Hamada AbdElgawad; Soad K Al Jaouni; Samy Selim; Salam A Ibrahim
Journal:  Plants (Basel)       Date:  2022-05-24

Review 2.  Momordica charantia L.-Diabetes-Related Bioactivities, Quality Control, and Safety Considerations.

Authors:  Serhat S Çiçek
Journal:  Front Pharmacol       Date:  2022-05-17       Impact factor: 5.988

3.  Bioactivity-Guided Isolation of Neuritogenic Factor from the Seeds of the Gac Plant (Momordica cochinchinensis).

Authors:  E Mazzio; R Badisa; S Eyunni; S Ablordeppey; B George; K F A Soliman
Journal:  Evid Based Complement Alternat Med       Date:  2018-05-31       Impact factor: 2.629

Review 4.  The Effect of Momordica charantia in the Treatment of Diabetes Mellitus: A Review.

Authors:  Zhuo Liu; Jing Gong; Wenya Huang; Fuer Lu; Hui Dong
Journal:  Evid Based Complement Alternat Med       Date:  2021-01-16       Impact factor: 2.629

5.  Preparation, Characterization, and Immuno-Enhancing Activity of Polysaccharides from Glycyrrhiza uralensis.

Authors:  Adila Aipire; Pengfei Yuan; Alimu Aimaier; Shanshan Cai; Mahepali Mahabati; Jun Lu; Tianlei Ying; Baohong Zhang; Jinyao Li
Journal:  Biomolecules       Date:  2020-01-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.